ABCA1 and atherosclerosis: Indeed, increasing cholesterol efflux by inhibition of ABCA1 protein degradation was shown to reduce atherosclerosis in mice36, and efflux capacity via ABCA1 was shown to inversely correlate with cardiovascular events in humans6,37.